Our guest today is Head of Pediatric Orthopedic department, Johanna Syvänen from Turku University Hospital. Johanna is a pediatric orthopedic surgeon with over 30 peer-reviewed scientific publications. Today she is here to discuss the recently published clinical paper: Allograft Versus Bioactive Glass (BG-S53P4) in Pediatric Benign Bone Lesions.

Our guest today is Head of Pediatric Orthopedic department, Johanna Syvänen from Turku University Hospital. Johanna is a pediatric orthopedic surgeon with over 30 peer-reviewed scientific publications. Today she is here to discuss the recently published clinical paper: Allograft Versus Bioactive Glass (BG-S53P4) in Pediatric Benign Bone Lesions.

Benefits of S53P4 bioactive glass in benign bone tumor surgery

Welcome to the Smart Healing™ Podcast, your go-to forum for engaging discussions with surgeons and authors about intriguing scientific papers. We understand that time is a precious commodity and there's a sea of fascinating scientific literature waiting to be explored. This podcast series is your go-to-source to guide you through the latest publications on Bonalive S53P4 bioactive glass. Bioactive glass, originally developed by Larry Hench from the United States, has been further developed by scientists in Turku, Finland providing the only formulation of Bioactive glass, S53P4, that inhibits bacterial growth. I’m your host, Tanja Wigell, serving as an International Product Manager at Bonalive Biomaterials. Join me as we delve into the captivating world of S53P4 bioactive glass and its myriad of applications for Smart Healing™.

Science

Life Sciences

Welcome to the Smart Healing™ Podcast, your go-to forum for engaging discussions with surgeons and authors about intriguing scientific papers. We understand that time is a precious commodity and there's a sea of fascinating scientific literature waiting to be explored. This podcast series is your go-to-source to guide you through the latest publications on Bonalive S53P4 bioactive glass. Bioactive glass, originally developed by Larry Hench from the United States, has been further developed by scientists in Turku, Finland providing the only formulation of Bioactive glass, S53P4, that inhibits bacterial growth. I’m your host, Tanja Wigell, serving as an International Product Manager at Bonalive Biomaterials. Join me as we delve into the captivating world of S53P4 bioactive glass and its myriad of applications for Smart Healing™.

Share Benefits of S53P4 bioactive glass in benign bone tumor surgery

Sign up to save your podcasts

Benefits of S53P4 bioactive glass in benign bone tumor surgery

Benefits of S53P4 bioactive glass in benign bone tumor surgery